PFIZER INC.

PFIZER INC. logo
🇺🇸United States
Ownership
Public
Established
1849-01-01
Employees
88K
Market Cap
$163.3B
Website
http://www.pfizer.com
Clinical Trials
Related News

Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg

Completed
Conditions
Rheumatoid Arthritis
Interventions
Drug: etanercept
First Posted Date
2005-09-19
Last Posted Date
2012-01-23
Lead Sponsor
Pfizer
Target Recruit Count
25
Registration Number
NCT00195338
Locations
🇱🇺

Pfizer Investigational Site, Luxembourg, Luxembourg

A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA

Completed
Conditions
Rheumatoid Arthritis
Interventions
Drug: Etanercept
First Posted Date
2005-09-19
Last Posted Date
2013-08-15
Lead Sponsor
Pfizer
Target Recruit Count
1014
Registration Number
NCT00195403

Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors

Phase 1
Completed
Conditions
Neoplasms
Interventions
Drug: bosutinib
First Posted Date
2005-09-19
Last Posted Date
2013-02-11
Lead Sponsor
Pfizer
Target Recruit Count
151
Registration Number
NCT00195260
Locations
🇺🇸

Pfizer Investigational Site, Seattle, Washington, United States

Use of 852A in Metastatic Cutaneous Melanoma.

First Posted Date
2005-09-19
Last Posted Date
2008-10-27
Lead Sponsor
Pfizer
Target Recruit Count
28
Registration Number
NCT00189332
Locations
🇫🇷

Hôpital Ste Marguerite,Service de Dermatologie, Marseilles, France

🇩🇪

Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany

🇩🇪

(DKFZ) an der Universitäts-Hautklinik Mannheim, Mannheim, Germany

and more 5 locations

Donepezil in the Prevention of Post-Operative Cognitive Decline

Phase 4
Completed
Conditions
Postoperative Complications
Delirium
First Posted Date
2005-09-16
Last Posted Date
2008-03-03
Lead Sponsor
Pfizer
Target Recruit Count
30
Registration Number
NCT00182845
Locations
🇺🇸

University Hospital, Clarian Health Partners, Indianapolis, Indiana, United States

Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.

Phase 4
Terminated
Conditions
Parkinson Disease
First Posted Date
2005-09-15
Last Posted Date
2007-05-25
Lead Sponsor
Pfizer
Target Recruit Count
220
Registration Number
NCT00174239
Locations
🇪🇸

Pfizer Investigational Site, Sevilla, Spain

Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia

Phase 3
Terminated
Conditions
Dementia, Vascular
Dementia, Mixed
Interventions
Drug: Donepezil
First Posted Date
2005-09-15
Last Posted Date
2015-03-24
Lead Sponsor
Pfizer
Target Recruit Count
149
Registration Number
NCT00174382
Locations
🇨🇦

Pfizer Investigational Site, Regina, Saskatchewan, Canada

MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer

Phase 2
Terminated
Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
Drug: PD-0325901
First Posted Date
2005-09-15
Last Posted Date
2009-03-17
Lead Sponsor
Pfizer
Target Recruit Count
34
Registration Number
NCT00174369
Locations
🇺🇸

Pfizer Investigational Site, Philadelphia, Pennsylvania, United States

Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer

Phase 1
Completed
Conditions
Breast Neoplasms
Interventions
Drug: SU011248
Drug: Paclitaxel
First Posted Date
2005-09-15
Last Posted Date
2009-01-27
Lead Sponsor
Pfizer
Target Recruit Count
22
Registration Number
NCT00174434
Locations
🇺🇸

Pfizer Investigational Site, New York, New York, United States

Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height

Phase 3
Completed
Conditions
Growth Disorder
First Posted Date
2005-09-15
Last Posted Date
2007-05-03
Lead Sponsor
Pfizer
Target Recruit Count
36
Registration Number
NCT00174421
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy